Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
The British Journal of Dermatology|February 26, 2016
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasisK A Papp, K Reich, C Paul, et al.
Molecular Metabolism|September 23, 2016
Male-lineage transmission of an acquired metabolic phenotype induced by grand-paternal obesityJennifer E Cropley, Sally A Eaton, Alastair Aiken, et al.
The British Journal of Dermatology|August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site InvolvementLinda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.
The New England Journal of Medicine|July 10, 2014
Secukinumab in plaque psoriasis--results of two phase 3 trialsRichard G Langley, Boni E Elewski, Mark Lebwohl, et al.
The British Journal of Dermatology|September 4, 2020
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trialA Blauvelt, C Leonardi, B Elewski, et al.
The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanomaE Jonasch, U N Kumar, G P Linette, et al.
The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.
Arthritis and Rheumatism|August 29, 2009
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitisVinod Chandran, Alice Gottlieb, Richard J Cook, et al.
American Journal of Medical Genetics. Part A|May 29, 2021
Syndromic neurodevelopmental disorder associated with de novo variants in DDX23William Burns, Lynne M Bird, Delphine Heron, et al.
Pageof 27